Table 1 of
Huang, Mol Vis 2013; 19:1211-1221. Table 1 of
Huang, Mol Vis 2013; 19:1211-1221.
Table 1. Characteristics of eligible studies included in this study
| Reference | Country (ethnicity) | Cases/ Controls | Genotyping method | Source of controls | Type of controls | Type of cases | Polymorphisms of VEGF-A gene |
|---|---|---|---|---|---|---|---|
| [23] | China (Asian) | 159/140 | MassArray | Hospital | Age, gender, and ethnicity matched without AMD | Neovascular AMD | rs833061, rs1413711, rs2010963, rs3025039 |
| [24] | Brazil (mixed) | 160/140 | TaqMan | Hospital | Age and gender matched without AMD, | Exudative and nonexudative AMD | rs1413711 |
| [25] | Finland (Caucasian) | 162/85 | TaqMan | Hospital | Age matched without AMD | Exudative AMD | rs699947, rs2146323, rs3025033 |
| [26] | Italy (Caucasian) | 226/248 | PCR-SBE | Hospital | Gender and ethnicity matched without detectable drusen | Neovascular and nonneovascular AMD | rs833068, rs833069, rs3024994, rs3025007, rs3025039 |
| [15] | Poland (Caucasian) | 265/136 | Allele-specific PCR and PCR-RFLP | Hospital | Age and gender matched without AMD | Atrophic and neovascular AMD | rs833061, rs2010963 |
| [27] | USA (Caucasian) | 211/187 | Hospital | Without AMD | Atrophic and neovascular AMD | rs833070 | |
| [16] | China (Asian) | 190/180 | PCR-RFLP | Hospital | Age and gender matched without any type of drusen, geographic atrophy, CNV, or other retinal disorder in either eye | Atrophic and neovascular AMD | rs699947, rs833061, rs1413711, rs2010963, rs3025039 |
| [28] | Australia (Caucasian) | 577/173 | MassArray | Population | Ethnicity and residence matched without AMD | Early, atrophic, and neovascular AMD | rs10434, rs25648, rs833061, rs2146323, rs3024997, rs3025030, rs3025035 |
| [13] | UK (Caucasian) | 45/94 | PCR | Hospital | Age matched healthy | Neovascular AMD | rs735286, rs1413711, rs2146323, rs3025021, rs3025024 |